IN THE NEWS

« Previous Release | Next Release »

Bothell, WA - Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced today it won the national 2009 IMCO Winner's Circle Vendor of the Year award. Independent Medical Co-Op, Inc. (IMCO) is a premier association for independent medical distributors.

IMCO functions as a full-service marketing group, uniting the best medical products in the industry with independent distributors located across the nation.

"Cardiac Science has always been an important vendor for IMCO, but the unwavering support from Cardiac Science through these challenging times is what earned them the Winner's Circle Vendor of the Year award," said Phil Childrey, IMCO director of equipment development. "Cardiac Science makes the IMCO Winner's Circle Program a component of its overall sales strategy, and its sales force does a remarkable job supporting our individual members."

"The Winner's Circle Vendor of the Year award is an important achievement for Cardiac Science since IMCO represents a significant distributor network for Cardiac Science products," said Darryl Lustig, Cardiac Science vice president of distribution.

"We work very closely with IMCO and value the relationship we've developed over the years," Lustig said. "This award demonstrates the sales possibilities when IMCO, its independent distributor members, and Cardiac Science work together."

About IMCO

IMCO was established in 1981, partnering with key manufacturers and all sizes of distributors throughout North America with the goal of uniting independent medical distributors to compete against the national competitors. IMCO was designed to keep the independent medical distributor independent through direct relationships with vendors and negotiating total volume pricing for their members.

About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick^®, HeartCentrix^®, Powerheart^®, and Quinton^® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's future AED sales in Japan, expected shipments of backordered products in the fourth quarter of 2010, and expectations regarding the closing of the transaction with Opto Circuits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks include those more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2009, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT

For more information, contact (media) info@cardiacscience.com | (investors) ir@optoindia.com | +91.80.2852.8088